Healthcare CFOs face growing pressure to fund innovation, optimize operations, and respond to regulatory and market dynamics. Portfolio rationalization is no longer optional—it’s a core strategic lever.
Low-ROI facilities, services, or business lines hinder transformation
Trapped resources limit funding for digital, outpatient, or AI-driven initiatives
Non-core assets may expose compliance, antitrust, or reputational risks
CFO diagnostic toolkit with financial, strategic, operational, market, and ESG criteria
Four-phase approach: strategic readiness, healthcare-specific valuation, carve-out execution, stakeholder navigation
Align divestiture proceeds with enterprise priorities: digital, telehealth, value-based care, and service line expansion
Real estate monetization, regulatory premium, and non-traditional buyers
Free up legacy assets to double down on transformative initiatives
Unlock trapped capital to self-fund growth and reduce reliance on debt
Phase-based divestment playbook ensures compliance and continuity
Enterprise healthcare CFOs and finance leaders responsible for portfolio management, strategic divestitures, and capital allocation.
Provides a multi-dimensional diagnostic framework covering financial, strategic, operational, market, and ESG factors.
Patient continuity, EHR/data separation, regulatory compliance, and HIPAA considerations require a specialized approach.
The playbook guides allocation into high-ROI initiatives such as digital care platforms, AI tools, telehealth, and ambulatory expansion.
A growth-focused scorecard tracks financial returns, market share impact, patient satisfaction, and digital adoption over multiple time horizons.
It frames divest-to-invest as a strategic discipline, embedding proactive portfolio reviews, data-driven decision-making, and agile capital deployment into organizational culture.
